Importantly, we noted increased frequencies of IFN-γ+ RCAN1-422-32 peptide-reactive T cells, but not RCAN1-177-87-reactive T cells, which were significantly elevated in PBMCs from GBM patients (Fig. 3K). This evidence concerns the gene IFNG and glioblastoma.